Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Review Article

SRP. 2020; 11(6): 568-579

Comparative Characteristics of Treatment Methods in Dogs Isosporosis and Giardiasis

Svetlana Shemyakova, Sergey Shabunin, Sergey Engashev, Veronika Lykhina, Yury Vatnikov, Evgeny Kulikov, Anna Orlova, Alfia Ibragimova, Tatiana Lobaeva, Alexander Strizhakov, Valentina Semenova, Marina Bolshakova.

Gastrointestinal tract diseases in dogs retain a leading position among other pathologies. At the same time, gastrointestinal parasites are among the most common pathogenic agents in dogs around the world and make a significant contribution to the development of severe gastroenteritis. Giardia sp. is a common cause of acute gastroenteritis in many animal species around the world. Proven participation of Giardia sp. in the development of chronic gastrointestinal disorders, leading to malabsorption and developmental delay in young animals, and, as a result, a decrease in resistance and an increase in susceptibility to reinvasion by giardia and various infections. In this regard, it seems relevant to study the pathogenetic features of the effect of protozoa on the mucous membrane of the small intestine of dogs for the development and improvement of therapeutic regimens. In our work, the therapy of giardiasis in domestic dogs with Drontal plus reinvasion for 6 months was not observed. When treating dogs with giardiasis and cystoisosporosis, the main antiprotozoal drug (Drontal for giardiasis or Stop-Coccid for cystoisosporosis) + antibiotic Cobactan + Probiotic Pro-Colin + vitamin B complex (Milgamma), the dogs were restored 100% on the 30th day after the end of treatment. During long-term follow-up of patients with clinical manifestations of gastrointestinal tract malfunction (a change in the consistency of feces towards softening, refusal to feed, and vomiting) with the use of a prebiotic was not observed.

Key words: Biochemical Blood Test, Complete Blood Count, Cystoisosporosis, Dogs, Giardiasis, Invasion.

Similar Articles

CircLphn3 protects the blood-brain barrier in traumatic brain injury.
Cheng YQ, Wu CR, Du MR, Zhou Q, Wu BY, Fu JY, Balawi E, Tan WL, Liao ZB
Neural regeneration research. 2022; 17(4): 812-818

Non-invasive gene delivery across the blood-brain barrier: present and future perspectives.
Kimura S, Harashima H
Neural regeneration research. 2022; 17(4): 785-787

Choice of ABO Group for Blood Component Transfusion in ABO-Incompatible Solid Organ Transplantation: A Questionnaire Survey in Korea and Guideline Proposal.
Chung Y, Ko DH, Lim J, Kim KH, Kim H
Annals of laboratory medicine. 2022; 42(1): 105-109

Clinical Evaluation of the Rapid STANDARD Q COVID-19 Ag Test for the Screening of Severe Acute Respiratory Syndrome Coronavirus 2.
Kim HW, Park M, Lee JH
Annals of laboratory medicine. 2022; 42(1): 100-104

An In Vitro Model System to Test Mechano-Microbiological Interactions Between Bacteria and Host Cells.
Santos LC, Munteanu EL, Biais N
Methods in molecular biology (Clifton, N.J.). 2022; 2364(): 217-235

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites